10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.

Slides:



Advertisements
Similar presentations
CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
Advertisements

Preventing Strokes One at a Time Acute Interventions and Management 2009.
Chronic Kidney Disease and Heart Disease: Understanding the Link Contributed by Elaine M. Koontz, RD, LD/N Review Date 8/13 R-0629 Provided Courtesy of.
The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.
JNC 8 Guidelines….
Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.
Assessment and Management of Patients With Hypertension.
The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure
For A Healthy Heart: Blood Pressure Management Presented by: Daniel Schimmel, MD, MS Assistant Professor of Medicine, Cardiology Bluhm Cardiovascular Institute.
Hypertension – Summary
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
Managing Diabetes Medications. Topics What medications are available to –Manage diabetes? –Lower blood pressure? –Improve cholesterol? How can you keep.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Pharmacological Treatment of Hypertension Update 2012.
Drugs for Hypertension
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
 Edmond 75 years presented with ‘shocking” blood pressure recordings of 184/102 in the morning. His afternoon and night readings were in the ‘acceptable.
0CTOBER 2010 An Approach for Sub-Saharan Africa. Dr. Linda Hawker, MD, CCFP General Practice Kelowna BC Canada.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) 2014 evidence-based guidelines for the management of high blood.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Hypertension (High Blood Pressure)
1 Current & New treatment strategies to address CV Risk.
UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,
Federal Study of Adherence to Medications (FAME) Trial Presented at The American Heart Association Annual Scientific Session 2006 Presented by Dr. Allen.
ALLHAT Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial JAMA 2002;288:
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
PHARMACOTHERAPY OF HYPERTENSION Based on New Guidelines Fariborz Nikaeen; MD Interventional cardiologist 2 november 2015.
Finding the Evidence Approximately 8,000 completed references are added to MEDLINE each week (over 400,000 added per year) Too much for any one person.
Michelle Gardner RN NUR-224. OBJECTIVES  Define normal blood pressure and categories of abnormal pressure  Identify risk factors for hypertension 
Dr.AZDAKI (cardiologist).   Initial monotherapy is successful in many patients with mild primary hypertension (formerly called "essential" hypertension).
Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.
Janice Herbert-Carter, MD, MGA, FACP Associate Professor of Medical Education.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Internal Medicine Workshop Series Laos September /October 2009.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
Date of download: 6/23/2016 From: Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive.
Date of download: 7/7/2016 From: Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American.
Joint reporting from Hill Physicians and Sutter Independent Physicians 1.
Management of Hypertension according to JNC 7
Hypertension In The Stroke Patient
Redefining Quality Care in T2DM Patients with CV Disease
Hypertension guidelines What’s all the controversy about 2015
JNC VIII Hypertension.
Hypertension JNC VIII Guidelines.
Nursing Care of Patients with Hypertension
Drugs for Hypertension
Management of High Blood Pressure in Blacks
Hypertension: A Risk Factor For Stroke
Progress and Promise in RAAS Blockade
Step Care Therapy for Hypertension in Diabetic Patients
Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.
Fig. 2. Evidence-based medication prescriptions
Table of Contents Why Do We Treat Hypertension? Recommendation 5
Pharmaceutical care planning 2 Ola Ali Nassr
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Chapter 32 Assessment and Management of Patients With Hypertension
Pharmacological Treatment of Hypertension Update 2012
Internal Medicine Workshop Series Laos September /October 2009
Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)
β-Blocker Use for the Stages of Heart Failure
Presentation transcript:

10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata Mukherjee, MD

Point 1 Hypertension currently affects nearly 78 million adults in the United States and is also a major modifiable risk factor for other cardiovascular diseases and stroke.

Point 2 High-quality blood pressure management is multifactorial and requires engagement of patients, families, providers, and health care delivery systems and communities. This includes expanding patient and health care provider awareness, appropriate lifestyle modifications, access to care, evidence- based treatment, a high level of medication adherence, and adequate follow-up.

Point 3 The identification of best practice, evidence-based management algorithms leading to standardization of treatment, is a critical element in helping to achieve national blood pressure control goals at a population level.

Point 4 Developing, disseminating, and implementing an effective hypertension treatment algorithm is a critical part of a multipronged systematic approach to controlling hypertension, as it facilitates clinical decision making, provides a default approach with proven benefits, and engages multiple providers in a coordinated manner.

Point 5 The blood pressure goal for an individual is set by utilizing a combination of factors including scientific evidence, clinical judgment, and patient tolerance. For most people, the goal is <140 and <90; however, lower targets may be appropriate for some populations such as African-Americans, the elderly, or patients with left ventricular hypertrophy, systolic or diastolic left ventricular dysfunction, diabetes mellitus, or chronic kidney disease..

Point 6 Lifestyle modifications should be initiated in all patients with hypertension, and they should be assessed for target organ damage and existing cardiovascular disease.

Point 7 Self-monitoring is encouraged for most patients throughout their care, and requesting and reviewing readings from home and community settings can help the provider assist the patient in achieving and maintaining good control.

Point 8 Treatment guidelines serve to facilitate a systematic approach to the management of hypertension, but provide appropriate modifications based on specific patient characteristics, preferences, and other pragmatic factors (e.g., cost, pill burden, risks of certain side effects) to optimize a personalized approach to the care of individual patients. Consider thiazides as first-line therapy in most patients.

Point 9 For patients with hypertension in combination with certain clinical conditions, specific medications should be considered first-line treatments. These include for: – Coronary artery disease/post-myocardial infarction: beta-blocker (BB), angiotensin-converting enzyme inhibitor (ACEI); – Systolic heart failure: ACEI or angiotensin-receptor blocker (ARB), BB, aldosterone antagonist, thiazide; – Diastolic heart failure: ACEI or ARB, BB, thiazide; – Diabetes: ACEI or ARB, thiazide, BB, calcium channel blocker; – Kidney disease: ACEI or ARB; and – Stroke or transient ischemic attack (TIA): thiazide, ACEI.

Point 10 The prevention of heart disease and stroke mandates a greater emphasis on the population-wide improvement of blood pressure awareness, treatment, and control, together with other cardiovascular health factors.